OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

CME GROUP INC. (CME) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

CME · CME GROUP INC.

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 41 filings · fetched 2026-11-13T17:00:37Z

Recent reported activity

2purchase rows on this page
3sale rows on this page
93matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-06-25Filed 2026-06-29Carey Charles PDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

References: F1

A Award / grantCommon Stock Class A · Non-derivative645A225Indirectby TrustForm 4 ↗0001341358-26-000003
2026-06-25Filed 2026-06-29Lucas Deborah JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

References: F1

A Award / grantCommon Stock Class A · Non-derivative645A225DirectForm 4 ↗0001329150-26-000003
2026-06-25Filed 2026-06-29SIEGEL HOWARD JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

References: F2

A Award / grantCommon Stock Class A · Non-derivative422A225DirectForm 4 ↗0001212853-26-000003
2026-06-25Filed 2026-06-29SIEGEL HOWARD JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

References: F1

A Award / grantCommon Stock Class A · Non-derivative645A225DirectForm 4 ↗0001212853-26-000003
2026-06-25Filed 2026-06-29SHEPARD WILLIAM RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

F3 Represents shares acquired pursuant to a broker-administered dividend reinvestment plan.

References: F3

P Purchase (market/private)Common Stock Class A · Non-derivative324.782A230.57Indirectby TrustForm 4 ↗0001212852-26-000003
2026-06-25Filed 2026-06-29SHEPARD WILLIAM RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

F3 Represents shares acquired pursuant to a broker-administered dividend reinvestment plan.

References: F3

P Purchase (market/private)Common Stock Class A · Non-derivative14.318A230.57DirectForm 4 ↗0001212852-26-000003
2026-06-25Filed 2026-06-29SHEPARD WILLIAM RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

F3 Represents shares acquired pursuant to a broker-administered dividend reinvestment plan.

References: F2

A Award / grantCommon Stock Class A · Non-derivative422A225DirectForm 4 ↗0001212852-26-000003
2026-06-25Filed 2026-06-29SHEPARD WILLIAM RDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

F3 Represents shares acquired pursuant to a broker-administered dividend reinvestment plan.

References: F1

A Award / grantCommon Stock Class A · Non-derivative645A225DirectForm 4 ↗0001212852-26-000003
2026-06-25Filed 2026-06-29GEPSMAN MARTIN JDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

References: F1

A Award / grantCommon Stock Class A · Non-derivative645A225DirectForm 4 ↗0001212813-26-000003
2026-06-25Filed 2026-06-29Ford Harold Eugene Jr.Director
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

References: F2

A Award / grantCommon Stock Class A · Non-derivative422A225DirectForm 4 ↗0001156375-26-000037
2026-06-25Filed 2026-06-29Ford Harold Eugene Jr.Director
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F2 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

References: F1

A Award / grantCommon Stock Class A · Non-derivative645A225DirectForm 4 ↗0001156375-26-000037
2026-05-25Filed 2026-09-17Sammann DerekOfficer · Sr MD Gl Hd Commodities Mkts
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934.

F2 Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.

F3 Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

References: F1

J Other reported codeCommon Stock Class A · Non-derivative4,629A0Indirectby TrustForm 4 ↗0001475318-26-000003
2026-05-25Filed 2026-09-17Sammann DerekOfficer · Sr MD Gl Hd Commodities Mkts
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934.

F2 Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.

F3 Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.

References: F1

J Other reported codeCommon Stock Class A · Non-derivative4,629D0DirectForm 4 ↗0001475318-26-000003
2026-05-18Filed 2026-05-19Piell Hilda HarrisOfficer · Sr MD & Chief HR Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

S Sale (market/private)Common Stock Class A · Non-derivative5,753D304.63DirectForm 4 ↗0001156375-26-000029
2026-05-15Filed 2026-05-18DUFFY TERRENCE ADirector · Officer · Chairman and CEO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.00 to $298.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.00 to $299.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

References: F2

S Sale (market/private)Common Stock Class A · Non-derivative9,004D299.58DirectForm 4 ↗0001212809-26-000004
2026-05-15Filed 2026-05-18DUFFY TERRENCE ADirector · Officer · Chairman and CEO
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.00 to $298.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.00 to $299.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

References: F1

S Sale (market/private)Common Stock Class A · Non-derivative25,996D298.14DirectForm 4 ↗0001212809-26-000004
2026-05-01Filed 2026-06-29Hobert William WDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a pro-rata, in-kind distribution of Class A Common Stock by WH Trading LLC to the Reporting Person for no consideration in a transaction exempt under Rule 16a-13. The Reporting Person received 20,320 shares in his individual capacity, which are now held directly. Previously, such shares were reported as being held indirectly by the Reporting Person. Effective May 1, 2026, the Reporting Person is no longer the managing member of WH Trading LLC. As a result of his retirement, the Reporting Person no longer shares voting or dispositive power over, or holds a reportable pecuniary interest in, the shares held of record by WH Trading LLC.

F2 The amount of securities beneficially owned reported in Column 5 has been adjusted to reflect an administrative tracking true-up of 20.531 shares due to a cumulative clerical error in the calculation of historical balances. This adjustment reflects the Reporting Person's actual beneficial ownership as of the date of this filing.

F3 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F4 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

References: F1, F2

J Other reported codeCommon Stock Class A · Non-derivative20,320A—DirectForm 4 ↗0001643402-26-000003
2026-05-01Filed 2026-06-29Hobert William WDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents a pro-rata, in-kind distribution of Class A Common Stock by WH Trading LLC to the Reporting Person for no consideration in a transaction exempt under Rule 16a-13. The Reporting Person received 20,320 shares in his individual capacity, which are now held directly. Previously, such shares were reported as being held indirectly by the Reporting Person. Effective May 1, 2026, the Reporting Person is no longer the managing member of WH Trading LLC. As a result of his retirement, the Reporting Person no longer shares voting or dispositive power over, or holds a reportable pecuniary interest in, the shares held of record by WH Trading LLC.

F2 The amount of securities beneficially owned reported in Column 5 has been adjusted to reflect an administrative tracking true-up of 20.531 shares due to a cumulative clerical error in the calculation of historical balances. This adjustment reflects the Reporting Person's actual beneficial ownership as of the date of this filing.

F3 Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

F4 At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.

References: F1

J Other reported codeCommon Stock Class A · Non-derivative20,320D—IndirectBy FirmForm 4 ↗0001643402-26-000003

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.